{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-25-015660","form_type":"8-K","ticker":"CSDX","cik":"0001106861","company_name":"CS DIAGNOSTICS CORP.","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.805952+00:00","generated_at":"2026-05-17T01:03:25.816397+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"CS Diagnostics completes conversion of Preferred B shares to 112.7M common shares; affiliates now hold common stock","bullets":["Conversion of all Series B Preferred Stock held by affiliates CS Interpharm and CS Diagnostics Pharma into 112,652,000 common shares.","Consolidates capital structure for consolidated financial reporting for FY ending Dec 31, 2025.","Affiliates' resales of converted shares remain subject to Rule 144 volume and manner-of-sale restrictions.","Benefits cited: enhanced transparency, improved efficiency, stronger alignment with common shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-25-015660","json":"https://secwatch.observer/filing/0001214659-25-015660.json","markdown":"https://secwatch.observer/filing/0001214659-25-015660.md","text":"https://secwatch.observer/filing/0001214659-25-015660.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106861/000121465925015660/0001214659-25-015660-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106861/000121465925015660/i10312518k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:03:25.816397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}